Action MJNA MEDICAL MARIJUANA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Medical Marijuana, Inc.

Actions

MJNA

US58463A1051

Marché Fermé - OTC Markets
Autres places de cotation
 21:53:46 07/05/2024 		Varia. 5j. Varia. 1 janv.
0,0023 USD 0,00% Graphique intraday de Medical Marijuana, Inc. -14,81% -37,84%
2023 Medical Marijuana, Inc. (OTCPK:MJNA) a acquis la quasi-totalité des actifs d'exploitation de KZ1 pour 5 millions de dollars. CI
2023 Medical Marijuana, Inc. annonce des changements au niveau de la direction CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings?
AXIM Biotechnologies, Inc. announced that it expects to receive $0.75 million in funding from Medical Marijuana, Inc.
Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.
Medical Marijuana, Inc. Announces Executive Changes
Medical Marijuana, Inc. Appoints Dr. Timothy R. Scott as Its New Chief Executive Officer
Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment
Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President
Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil
GRN Holdings Corporation, Inc. (OTC: GRNF) Announces Name Change to Marijuana Inc., New Management and Business Model
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Health & Wellness Podcast; Secures Features in Top Brazil Lifestyle Publications
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action MJNA
  4. Actualités Medical Marijuana, Inc.
  5. Autres langues